To identify metastasis-specific alterations in the composition and gene expression of KP_Pos (KRT18+PTPRC+) cells, we conducted an integrated single-cell transcriptomic analysis of benign, primary, and metastatic prostate cancer tissues. This evidence concerns the gene KRT18 and prostate carcinoma.